Aspire BioPharma is trading at $7.30, down 6.29%, with no separate after-hours catalyst confirmed.
- Regular-session close was $7.79, following a 0.78% gain.
- The company completed its approximately $30 million Dura Driver acquisition August 10, financed partly through a $22.5 million revolving facility.
- The announcement preceded the decline, and no direct connection was reported; the reason remains unclear.